More than a dozen international speakers will address a conference this Thursday on the latest developments in medicine and healthcare.
The conference is being organised by students from University College Cork. It will take place virtually and there is no fee.
This is the first Transational Medicine Conference - translational medicine aims to improve human health and longevity by determining the relevance to human disease of new discoveries in the biological sciences.
Laboratory discoveries are progressed to clinical applications in what is known as a "bench-to-bedside" approach.
"Translational Medicine is a multi-disciplinary, highly-collaborative approach to improving human health," explains Maedbh Heaney, co-founder and chairperson of the Society of Translational Medicine at University College Cork.
Speakers at the conference include Trinity College Biochemist, Professor Luke O'Neill; Professor of Neonatal Physiology, Geraldine Boylan of UCC and Cork University Maternity Hopsital's Infant research centre; and Dr Dan Barouch, Lead Immunologist at Johnson & Johnson Covid-19 Vaccine Candidate.
Registration for the conference can be completed here.
Maedbh Heaney explains that the aim of the conference is to develop a collaborative approach to improving human health by converting laboratory discoveries into clinical applications which will benefit patients.
"Translational medicine strives to enhance healthcare by facilitating rapid and successful translation of scientific knowledge to clinical implementation," she says.
"This modern approach has emerged from the increasing need to stop the evolution of disease treatment and prevention being lost in translation between what we know and what we practise.
"To do this we must equip people with translational skills, in order to lift the silos between disciplines and promote inter-institutional and entrepreneurial collaboration."
